Destination Maternity (DESTQ) Form 3 Destination Maternity / David L Courtright ownership change

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:	3235-0104
Estimated average burden
hours per response:	0.5

1. Name and Address of Reporting Person^*

Courtright David L

(Last) (First) (Middle)

C/O DESTINATION MATERNITY CORPORATION

232 STRAWBRIDGE DRIVE

(Street)

MOORESTOWN NJ 08057

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
05/09/2016

3. Issuer Name and Ticker or Trading Symbol
Destination Maternity Corp [ DEST ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
	Officer (give title below)	X	Other (specify below)
Principal Accounting Officer

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	23,027.7089(1)(2)	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Options (Right to Buy)	(3)	11/19/2018	Common Stock	200	3.515	D
Stock Options (Right to Buy)	(4)	01/29/2020	Common Stock	400	11.89	D
Stock Options (Right to Buy)	(5)	03/03/2021	Common Stock	600	22.13	D
Stock Options (Right to Buy)	(6)	11/18/2021	Common Stock	1,500	14.51	D
Stock Options (Right to Buy)	(7)	11/16/2022	Common Stock	2,000	19.89	D
Stock Options (Right to Buy)	(8)	11/22/2023	Common Stock	1,500	31.38	D
Stock Options (Right to Buy)	(9)	12/05/2024	Common Stock	7,980	14.3	D
Stock Options (Right to Buy)	(10)	03/30/2026	Common Stock	13,300	7.49	D

Explanation of Responses:

1. Includes 10,893 shares of unvested restricted stock. This includes 500 shares from the November 16, 2012 grant of 2,000 shares, which shares vest in four (4) equal annual installments beginning on November 16, 2013; 750 shares from the November 22, 2013 grant of 1,500 shares, which shares vest in four (4) equal annual installments beginning on November 22, 2014; and 2,993 shares from the December 5, 2014 grant of 3,990 shares, which shares vest in annual installments over a four (4) year period beginning on December 5, 2015 as follows: 997 shares vest on each of December 5, 2015 and December 5, 2017, and 998 shares vest on each of December 5, 2016 and December 5, 2018. Continued in next footnote.

2. Also includes 6,650 shares from the March 30, 2016 grant of 6,650 shares, which shares vest in annual installments over a four (4) year period beginning on March 30, 2017 as follows: 1,662 shares vest on each of March 30, 2017 and March 30, 2019, and 1,663 shares vest on each of March 30, 2018 and March 30, 2020. 2,384.7089 of these shares were purchased by the Reporting Person pursuant to the Issuer's Employee Stock Purchase Plan.

3. On November 19, 2008, options to purchase 1,000 shares were granted to the Reporting Person by the Issuer. The options vest and are exercisable in five (5) equal annual installments beginning on November 19, 2009. All of the remaining outstanding November 19, 2008 options are vested.

4. On January 29, 2010, options to purchase 1,000 shares were granted to the Reporting Person by the Issuer. The options vest and are exercisable in five (5) equal annual installments beginning on January 29, 2011. All of the remaining outstanding January 29, 2010 options are vested.

5. On March 3, 2011, options to purchase 1,000 shares were granted to the Reporting Person by the Issuer. The options vest and are exercisable in five (5) equal annual installments beginning on March 3, 2012. All of the remaining outstanding March 3, 2011 options are vested.

6. On November 18, 2011, options to purchase 2,000 shares were granted to the Reporting Person by the Issuer. The options vest and are exercisable in four (4) equal annual installments beginning on November 18, 2012. All of the remaining outstanding November 18, 2011 options are vested.

7. On November 16, 2012, options to purchase 2,000 shares were granted to the Reporting Person by the Issuer. The options vest and are exercisable in four (4) equal annual installments beginning on November 16, 2013. 1,500 of the outstanding November 16, 2012 options are vested and 500 are unvested.

8. On November 22, 2013, options to purchase 1,500 shares were granted to the Reporting Person by the Issuer. The options vest and are exercisable in four (4) equal annual installments beginning on November 22, 2014. 750 of the outstanding November 22, 2013 options are vested and 750 are unvested.

9. On December 5, 2014, options to purchase 7,980 shares were granted to the Reporting Person by the Issuer. The options vest and are exercisable in four (4) equal annual installments beginning on December 5, 2015. 1,995 of the outstanding December 5, 2014 options are vested and 5,985 are unvested.

10. On March 30, 2016, options to purchase 13,300 shares were granted to the Reporting Person by the Issuer. The options vest and are exercisable in four (4) equal annual installments beginning on March 30, 2017. All of the outstanding March 30, 2016 options are unvested.

Remarks:

	David L. Courtright	05/18/2016
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.